Ramaphosa launches national rollout of long-acting HIV prevention injection Lenacapavir

President Cyril Ramaphosa officially launched South Africa’s rollout of the long-acting HIV prevention injection Lenacapavir in Secunda, Mpumalanga today, marking a new addition to the country’s biomedical HIV prevention tools.

Twice-yearly injection added to prevention options

Lenacapavir is a long-acting injectable given twice a year and is being introduced as an alternative to existing HIV prevention methods. The Presidency described the rollout as a major milestone in South Africa’s fight against HIV/AIDS and its efforts to reduce new infections.

High-profile launch with government and partners

The launch was attended by Health Minister Aaron Motsoaledi, Mpumalanga Premier Mandla Ndlovu, provincial health MECs and representatives from civil society under the South African National AIDS Council (SANAC). Development partners and donors, including the Global Fund, were also expected to attend.

Government framing

“This groundbreaking initiative marks a significant milestone in South Africa’s ongoing efforts to fight against HIV/AIDS and aims to enhance prevention of new HIV infections,” the Presidency said.

Collaboration highlighted

Officials said the initiative reflects strengthened collaboration between government, civil society, the private sector and international partners in the drive to end HIV as a public health threat in South Africa.